Ethyl 6-bromo-1H-imidazo[4,5-b]pyridine-2-carboxylate

Catalog No. :
ACGWIL720
CAS No. :
954217-58-4
Molecular Formula :
C9H8BrN3O2
Molecular Weight :
270.09

IUPAC Name:ethyl 6-bromo-1H-imidazo[4,5-b]pyridine-2-carboxylate

Ethyl 6-bromo-1H-imidazo[4,5-b]pyridine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$353.00Login to see priceInquiryInquiry
250mg97%$564.00Login to see priceInquiryInquiry
1g97%$1412.00Login to see priceInquiryInquiry
5g97%$4236.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 6-bromo-1H-imidazo[4,5-b]pyridine-2-carboxylate
IUPAC Nameethyl 6-bromo-1H-imidazo[4,5-b]pyridine-2-carboxylate
MDL No.MFCD19441298
Molecular FormulaC9H8BrN3O2
Molecular Weight270.09
SMILESO=C(C1=NC2=NC=C(Br)C=C2N1)OCC
InChI KeyNJZUANIECDYRNO-UHFFFAOYSA-N
Synonym6-BroMo-1H-IMidazo[4,5-b]pyridine-2- carboxylic acid ethyl ester;ethyl 6-bromo-1H-imidazo[4,5-b]pyridine-2-carboxylate;3H-Imidazo[4,5-b]pyridine-2-carboxylic acid, 6-bromo-, ethyl ester
CAS No.954217-58-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGWIL720 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBKI731 route compound structure diagram
    ACFBKI731617-37-8 In Stock
  2. Plus
  3. ACNPOX072 route compound structure diagram
    ACNPOX07238875-53-5 In Stock
  4. Then
  5. ACGWIL720 route product structure diagram
    ACGWIL720954217-58-4
Inquiry

2. ACGWIL720 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGWIL720 route product structure diagram
    ACGWIL720954217-58-4
Inquiry

Comments (0)